investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

David A Fruman

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Related projects

Joseph L Wiemels

Genome-Wide Association Study of Childhood Leukemia by Hispanic Status

Leukaemia

Hematology and hematologic malignancies

Richard J Jones

Bone Marrow Transplantation in Human Disease

Leukaemia

Hematology and hematologic malignancies

Martine Extermann

Decision Models to Compare Treatments in Older Patients with AML

Leukaemia

Hematology and hematologic malignancies

Jun J Yang

ARID5B and Disparities of Childhood Leukemia

Leukaemia

Hematology and hematologic malignancies

Kenneth C Anderson

Specialized Program of Research Excellence (SPORE) in Multple Myeloma

Leukaemia

Hematology and hematologic malignancies Pathology

George P Studzinski

Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer

Leukaemia

Hematology and hematologic malignancies Pathology

Ronald Hoffman

A New Murine Model for MPN: Pathology and Therapy of NF-E2 Overexpression

Leukaemia

Hematology and hematologic malignancies Pathology

James L M Ferrara

Cellular and Molecular Studies of Bone Marrow Transplant

Leukaemia

Hematology and hematologic malignancies

Michele S Redell

Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML

Leukaemia

Hematology and hematologic malignancies